Adverse Drug Reactions - Part II
COURSE NUMBER: 537
Kristin A. Williams, DDS, MPH; M. Louay Taifour, BDS, DMD
This course discusses common immune-mediated and idiosyncratic adverse drug reactions (ADRs) related to the top 200 drugs dispensed by U.S. community pharmacies and less commonly noted ADRs affecting oral tissues. In addition, uncommon, tim...
(Use this feature to create assignments for your students and staff.)
This course discusses common immune-mediated and idiosyncratic adverse drug reactions (ADRs) related to the top 200 drugs dispensed by U.S. community pharmacies and less commonly noted ADRs affecting oral tissues. In addition, uncommon, time-related (delayed), usually dose-related ADRs, i.e., carcinogenesis and teratogenesis, and some secondary ADRs are presented.
Dentists, Dental Hygienists, Dental Assistants, Dental Students, Dental Hygiene Students, Dental Assisting Students
Date Course Online:
Aug 1, 2017
Last Revision Date:
Jul 1, 2019
Course Expiration Date:
Dec 30, 2022
AGD Subject Code(s):
Upon completion of this course, the dental professional should be able to:
- Discuss in general terms the mechanisms of immune-mediated, idiosyncratic, oncogenic, teratogenic and secondary ADRs.
- Discuss the spectrum of potential immune-mediated, idiosyncratic, oncogenic, teratogenic and secondary ADRs.
- Discuss issues related to preventing, diagnosing, and reporting ADRs.
- P&G is providing these resource materials to dental professionals. We do not own this content nor are we responsible for any material herein.
- Participants must always be aware of the hazards of using limited knowledge in integrating new techniques or procedures into their practice. Only sound evidence-based dentistry should be used in patient therapy.
Note: Registration is required to take test.
Academy of General Dentistry (AGD) Submission For credit transfers to appear in your AGD account in real time, make sure to add your AGD membership number in the field provided on the “Share Your Test Score” page.
CE Broker For all states that use CE Broker for licensure, “proof of completions” are electronically reported the first of every month. If a course was taken in November, the “proof of completion” will be submitted the beginning of December.
ADA CERP Recognized Provider
The Procter & Gamble Company is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
Concerns or complaints about a dental CE provider may be directed to the provider or to ADA CERP at:
Approved PACE Program Provider
THE PROCTER & GAMBLE COMPANY
Nationally Approved PACE Program Provider for FAGD/MAGD credit.
Approval does not imply acceptance by any regulatory authority or AGD endorsement.
8/1/2021 to 7/31/2027
Provider ID# 211886
AADH Approved Program Provider
Procter & Gamble is designated as an approved Provider by the American Academy of Dental Hygiene, Inc. #AADHPGC (January 1, 2022-December 31, 2023). Approval does not imply acceptance by a state or provincial Board of Dentistry. Licensee should maintain this document in the event of an audit.